All Substitutes
Loading...
Disclaimer
Did you find this information helpful?
Erlogem 150mg Tablet
Prescription Required
Salt Composition : Erlotinib
Manufacturer : ADMAC LIFE SCIENCES
Origin of Medicine : India
10 Tablet(s) In A Strip
Introduction to Erlogem 150mg Tablet
Erlogem 150 mg Tablet is an anticancer medicine containing the active constituent erlotinib. It is used to treat non-small lung cancer (NSCLC) and pancreatic cancer. Cancer is a disorder in which cells multiply in an uncontrolled and abnormal manner. It is usually given in combination with other anticancer medicine, gemcitabine, for patients with metastatic or advanced pancreatic cancers.
Inform the doctor if you use contact lenses, have an intolerance to sugars, have a history of eye problems, or if any medicines are taken for clotting disorders or cholesterol. This medication can cause eye dryness and conjunctivitis and hence patients are advised to inform the history of vision problems, use of contact lenses before taking this medication. Erlogem 150 mg Tablet is not recommended for adolescents and children under the age of 18. Do not take this medication with food. Use effective birth control during the treatment and for at least 2 weeks after the last dose.
Patients are advised not to smoke while being treated with Erlogem 150 mg Tablet, as smoking may decrease the amount of medicine in the blood. Wear protective clothing and sunscreen while going outside. Inform the physician if the patient has any symptoms like pain in the eye, blurred vision, cough, fever, shortness of breath, severe abdominal pain, and persistent diarrhea while taking this medicine.
Uses of Erlogem 150mg Tablet
- Advanced or metastatic non-small lung cancer (NSCLC)
- Advanced or metastatic pancreatic cancer
Therapeutic Effects of Erlogem 150mg Tablet
Erlogem 150 mg prevents the activity of a protein called epidermal growth factor receptor (EFGR), a protein involved in the spread and growth of cancer cells.
Interaction of Erlogem 150mg Tablet with other drugs
Inform your doctor about any prescribed medications, over-the-counter medicines, nutritional and vitamin supplements, and herbal products you take or have taken before the treatment. Certain medications may interact with Erlogem 150 mg tablet and cause undesirable side effects.
More Information about Erlogem 150mg Tablet
Keep out of sight and reach of children. Store at a controlled room temperature between 15°C to 30°C. Do not freeze.
How to consume Erlogem 150mg Tablet
Erlogem 150 mg prevents the activity of a protein called epidermal growth factor receptor (EFGR), a protein involved in the spread and growth of cancer cells.
Safety Advices for Erlogem 150mg Tablet
Pregnancy
Taking Erlogem 150 mg while pregnant can harm the baby. Do not take this medicine during pregnancy unless your doctor recommends taking it. Inform your doctor if you are pregnant or planning to be pregnant before taking this medicine.
Breast Feeding
Do not take Erlogem 150 mg if you are breastfeeding. Consult the doctor for risks and benefits.
Lungs
It is unknown whether Erlogem 150 mg Tablets affect the lungs. Please consult your doctor.
Liver
This medicine is not recommended in patients with severe liver diseases. Inform the physician about any liver disorders.
Alcohol
It is unknown whether it is safe to consume alcohol with Erlogem150 mg Tablets. Please consult your doctor.
Driving
It is not known whether Erlogem 150 mg Tablet alters the ability to drive. Do not drive if you experience symptoms affecting your ability to concentrate and react.
Side Effects of Erlogem 150mg Tablet
Side effects are unwanted symptoms caused by medicines. Even though all medicines cause side effects, not everyone gets them.
Serious:
- Persistent or severe diarrhea
- Pain in the eye, blurred vision
- Sudden difficulty in breathing accompanied by cough and fever
- Severe pain in your abdomen
- Liver failure
Common:
- Rash, worsened in sun-exposed areas
- Loss of appetite, decreased weight
- Infection
- Headache
- Depression
- Nausea
- Mouth irritation
- Indigestion
- Hair loss, dry skin, itching, acne, cracked skin
- Tiredness
- Inflammation around fingernail
- Bleeding from nose, stomach, intestines
- Reduced kidney function
Word of Advice
Inform the doctor if you have vision problems, are using contact lenses, have clotting disorders, intolerance to sugar, and taking any medication for cholesterol before starting this medication. This medication should not be taken along with the food, and it can be taken either before or after food as it increases the effectiveness of the medication. It is not recommended for individuals below 18 years of age. Inform the doctor about kidney, and liver disorders as this medication is not recommended in patients with kidney and liver disorders. Avoid making plans to have children or during pregnancy because this medicine is highly unsafe and causes harmful effects on the developing baby.
FAQs
Q 1. How should I take Erlogem 150 mg?
Always take this medicine as prescribed by the doctor.The tablet must be taken at least one hour before or two hours after taking food and it should be taken at a fixed time daily.
Q 2. Does Erlogem 150 mg cause eye dryness?
Yes, this medication can cause eye dryness and conjunctivitis and hence patients are advised to inform the history of vision problems, use of contact lenses before taking this medication.
Q 3. Can I take Erlogem 150 mg during pregnancy?
This medication is highly unsafe in pregnancy as it can cause harmful effects in the developing baby. Avoid making plans to have children or during pregnancy while taking this medication.
Q 4. Can I smoke while taking Erlogem 150 mg?
Avoid smoking while taking this medication, as it can decrease the effectiveness of this medication.
Q 5. How long can I take Erlogem 150 mg?
Erlogem 150 mg is taken daily as long as prescribed by the doctor and duration of time varies from patient to patient depending upon the severity of the disease
Q 6. Can Erlogem 150 mg be used in kidney disorders?
This medication is not recommended in kidney patients as it can worsen the condition of the disease.
Fact Box of Erlogem 150mg Tablet
Molecule name: Erlotinib | Therapeutic class: Tyrosine kinase inhibitor |
Pharmacological class: Anti-Neoplastics | Indications: 1. Advanced or metastatic non-small lung cancer (NSCLC) 2. Advanced or metastatic pancreatic cancer |
References
- Goodman & Gilman’s, The Pharmacological Basis of Therapeutics, Targeted Therapies: Tyrosine Kinase Inhibitors, Monoclonal Antibodies, and Cytokines, 12th edition, 2011, 1735-1737.
- Mylan, Electronic medicines compendium (emc), [ Revised on Jan 2020] [ Accessed on 14th April 2021], https://www.medicines.org.uk/emc/files/pil.11264.pdf
- Genentech, US Food and Drug Administration, [ Revised on April 2010] [ Accessed on 14th April 2021], https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021743s14s16lbl.pdf
Disclaimer
MrMed’s primary intention is to ensure that its consumers get information that is reviewed by experts, accurate and trustworthy. The information and contents of this website are for informational purposes only. They are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of your doctor and discuss all your queries related to any disease or medicine. Do not disregard professional medical advice or delay in seeking it because of something you have read on MrMed. Our mission is to support, not replace, the doctor-patient relationship.
4000+ products
We maintain strict quality controls on all our partner retailers, so that you always get standard quality products.
Secure Payment
100% secure and trusted payment protection
Easy Return
We have a new and dynamic return window policy for medicines and healthcare items. Refer FAQs section for more details.
